Xavier Barril

Session 1: The impact of AI-based tools and data science in Drug Discovery

ICREA & Universitat de Barcelona

Dr. Barril is an ICREA Research Professor at the University of Barcelona, School of Pharmacy. His research focuses on the discovery of bioactive molecules exploiting new mechanisms of action and the development of computational methods to achieve this goal efficiently.

He is a well-known expert in the field of structure-based drug discovery, with >90 scientific publications, 15 supervised Doctoral theses and 40 invited talks at international conferences.

He also has a strong focus on applied research and experience in the private sector: co-inventor of 14 patents, applications scientist at Vernalis (2002-2005), co-founder of Minoryx Therapeutics (2011-2017), part-time CTO at Gain Therapeutics (2018-present) & co-founder of Oniria Therapeutics (2021-present)